15 July 2008: Denise Ström Appointed to CM&D Pharma Scientific Board Chertsey, 15th July 2008. CM&D Pharma Limited (CM&D), the European niche specialty company, today announced the appointment of Denise Ström, MRPharmS, to its Scientific Board. A qualified pharmacist, Ms Ström worked for a short time in retail pharmacy before an appointment in clinical research and regulatory affairs for Solvay BV in the Netherlands.  Since then, Denise has worked at a senior level for both pharmaceutical companies and regulatory consultants, including Wyeth Laboratories, BIOS Consultancy, Fujisawa Pharmaceuticals, Norton Healthcare, Cortecs and A. Nelson and Company.  She joins CM&D from Sinclair Pharmaceuticals, where she was Director of Regulatory Affairs, with responsibilities including pharmacovigilance, medical information and reimbursement. Ms Ström is an active member of both the Royal Pharmaceutical Society of Great Britain and The Organisation for Professionals in Regulatory Affairs (TOPRA).  She has a depth of experience in both the USA and Europe, including clinical trial protocols, regulatory applications and expert reports across a broad range of therapeutic classes. Stephen Appelbee, CEO of CM&D said: ‘CM&D is now entering a crucial phase in the development of its portfolio of exciting new medicines.  As well as offering regulatory oversight, Denise’s strengths will have an important influence over the implementation of our buy and build corporate strategy.  Her skills will provide a vital resource as we integrate our acquisitions across Europe.’ Further information:  Stephen Appelbee, +44 1932 796083, appelbee@cmdpharmaltd.com > Back